INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
LP

Liptak Vincent Paul

General CounselCIK 0002143905

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells2 / 0
Max Insider Score34
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Grant or award
A—
46.6K sh
Aug 6, 2026Aug 10, 2026
traded Aug 6, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    BlossomHill Therapeutics, Inc.General Counsel · Aug 10, 2026
34
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Open-market purchase
BUY
$40K
2,500 sh
Aug 7, 2026
Aug 10, 2026
traded Aug 7, 2026
+3d
SEC FORM 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC FORM 4

Evidence

5
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Derivative conversion
C—
22.7K sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC FORM 4

Evidence

30
LP
Liptak Vincent PaulGeneral Counsel
BLSMBlossomHill Therapeutics, Inc.
Open-market purchase
BUY$35K
2,200 sh
Aug 10, 2026Aug 10, 2026
traded Aug 10, 2026
+0dSEC FORM 4

Evidence